Literature DB >> 28651852

Differences in Repolarization Heterogeneity Among Heart Failure With Preserved Ejection Fraction Phenotypic Subgroups.

Suzanne K Oskouie1, Stuart B Prenner1, Sanjiv J Shah1, Andrew J Sauer2.   

Abstract

Heart failure with preserved ejection fraction (HFpEF) is a highly heterogeneous syndrome associated with multiple medical comorbidities and pathophysiologic pathways or phenotypes. We recently developed a phenomapping method combining deep phenotyping with machine learning analysis to classify HFpEF patients into 3 clinically distinct phenotypic subgroups (phenogroups) with different clinical outcomes. Phenogroup #1 was younger with lower B-type natriuretic peptide levels, phenogroup #2 had the highest prevalence of obesity and diabetes mellitus, and phenogroup #3 was the oldest with the most factors for chronic kidney disease, the most dysfunctional myocardial mechanics, and the highest adverse outcomes. The pathophysiological differences between these phenogroups, however, remain incompletely described. We sought to evaluate whether these 3 groups differ on the basis of repolarization heterogeneity, which has previously been linked to adverse outcomes in HFpEF. The T-peak to T-end (TpTe) interval, a well-validated index of repolarization heterogeneity, was measured by 2 readers blinded to each other and all other clinical data on the electrocardiograms of 201 HFpEF patients enrolled in a systematic observational study. TpTe duration was associated with higher B-type natriuretic peptide level (p = 0.006), increased QRS-T angle (p = 0.008), and lower septal e' velocity (p = 0.007). TpTe duration was greatest in phenogroup #3 (100.4 ± 24.5 ms) compared with phenogroups #1 (91.2 ± 17.3 ms) and #2 (90.2 ± 17.0 ms) (p = 0.0098). On multivariable analyses, increased TpTe was independently associated with the high-risk phenogroup #3 classification. In conclusion, repolarization heterogeneity is a marker of a specific subset of HFpEF patients identified using unsupervised machine learning analysis and therefore may be a key pathophysiologic marker in this subset of HFpEF patients.
Copyright © 2017 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28651852     DOI: 10.1016/j.amjcard.2017.05.031

Source DB:  PubMed          Journal:  Am J Cardiol        ISSN: 0002-9149            Impact factor:   2.778


  4 in total

1.  Guideline of the Brazilian Society of Cardiology on Telemedicine in Cardiology - 2019.

Authors:  Marcelo Antônio Cartaxo Queiroga Lopes; Gláucia Maria Moraes de Oliveira; Antonio Luiz Pinho Ribeiro; Fausto J Pinto; Helena Cramer Veiga Rey; Leandro Ioschpe Zimerman; Carlos Eduardo Rochitte; Fernando Bacal; Carisi Anne Polanczyk; Cidio Halperin; Edson Correia Araújo; Evandro Tinoco Mesquita; José Airton Arruda; Luis Eduardo Paim Rohde; Max Grinberg; Miguel Moretti; Paulo Ricardo Avancini Caramori; Roberto Vieira Botelho; Andréa Araújo Brandão; Ludhmila Abrahão Hajjar; Alexandre Fonseca Santos; Alexandre Siciliano Colafranceschi; Ana Paula Beck da Silva Etges; Bárbara Campos Abreu Marino; Bruna Stella Zanotto; Bruno Ramos Nascimento; Cesar Rocha Medeiros; Daniel Vitor de Vasconcelos Santos; Daniela Matos Arrowsmith Cook; Eduardo Antoniolli; Erito Marques de Souza Filho; Fábio Fernandes; Fabio Gandour; Francisco Fernandez; Germano Emilio Conceição Souza; Guilherme de Souza Weigert; Iran Castro; Jamil Ribeiro Cade; José Albuquerque de Figueiredo Neto; Juliano de Lara Fernandes; Marcelo Souza Hadlich; Marco Antonio Praça Oliveira; Maria Beatriz Alkmim; Maria Cristina da Paixão; Maurício Lopes Prudente; Miguel A S Aguiar Netto; Milena Soriano Marcolino; Monica Amorim de Oliveira; Osvaldo Simonelli; Pedro A Lemos Neto; Priscila Raupp da Rosa; Renato Minelli Figueira; Roberto Caldeira Cury; Rodrigo Coelho Almeida; Sandra Regina Franco Lima; Silvio Henrique Barberato; Thiago Inocêncio Constancio; Wladimir Fernandes de Rezende
Journal:  Arq Bras Cardiol       Date:  2019-11       Impact factor: 2.000

2.  Electrocardiographic characteristics in patients with heart failure and normal ejection fraction: A systematic review and meta-analysis.

Authors:  Theodora Nikolaidou; Nathan A Samuel; Carl Marincowitz; David J Fox; John G F Cleland; Andrew L Clark
Journal:  Ann Noninvasive Electrocardiol       Date:  2019-10-11       Impact factor: 1.468

Review 3.  Artificial intelligence in cardiology.

Authors:  Diana Bonderman
Journal:  Wien Klin Wochenschr       Date:  2017-10-04       Impact factor: 1.704

4.  The anti-aging factor Klotho protects against acquired long QT syndrome induced by uremia and promoted by fibroblast growth factor 23.

Authors:  José Alberto Navarro-García; Rafael Salguero-Bodes; Laura González-Lafuente; Laura Martín-Nunes; Elena Rodríguez-Sánchez; Teresa Bada-Bosch; Eduardo Hernández; Evangelina Mérida-Herrero; Manuel Praga; Jorge Solís; Fernando Arribas; Héctor Bueno; Makoto Kuro-O; María Fernández-Velasco; Luis Miguel Ruilope; Carmen Delgado; Gema Ruiz-Hurtado
Journal:  BMC Med       Date:  2022-01-19       Impact factor: 8.775

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.